Transcend Capital Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.83M | Sell |
|
|||||
|
2025
Q1 | $3.94M | Sell |
|
|||||
|
2024
Q4 | $4.44M | Sell |
|
|||||
|
2024
Q3 | $5.02M | Sell |
|
|||||
|
2024
Q2 | $5.02M | Buy |
|
|||||
|
2024
Q1 | $4.78M | Buy |
|
|||||
|
2023
Q4 | $4.3M | Buy |
|
|||||
|
2023
Q3 | $2.31M | Buy |
|
|||||
|
2023
Q2 | $1.06M | Sell |
|
|||||
|
2023
Q1 | $976K | Sell |
|
|||||
|
2022
Q4 | $1.14M | Sell |
|
|||||
|
2022
Q3 | $1.48M | Buy |
|
|||||
|
2022
Q2 | $1.38M | Buy |
|
|||||
|
2022
Q1 | $1.36M | Sell |
|
|||||
|
2021
Q4 | $1.7M | Buy |
|
|||||
|
2021
Q3 | $613K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $851K | Buy |
|
|||||
|
2020
Q4 | $877K | Sell |
|
|||||
|
2020
Q3 | $855K | Buy |
|